Startseite>>Infectious Disease>> Bacterial Diseases>> Pneumonia>>Cefadroxil-d4 (trifluoroacetate salt)

Cefadroxil-d4 (trifluoroacetate salt)

Katalog-Nr.GC48489

An internal standard for the quantification of cefadroxil

Products are for research use only. Not for human use. We do not sell to patients.

Cefadroxil-d4 (trifluoroacetate salt) Chemische Struktur

Cas No.: 1426215-61-3

Größe Preis Lagerbestand Menge
500µg
170,00 $
Auf Lager
1mg
321,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Cefadroxil-d4 is intended for use as an internal standard for the quantification of cefadroxil by GC- or LC-MS. Cefadroxil is a semisynthetic cephalosporin antibiotic.1 It is active against a variety of Gram-positive and Gram-negative bacteria, including B. anthracis, V. cholerae, and P. multocida strains (MICs = 1, 2, and 4 µg/ml, respectively), among others. Cefadroxil is protective against infection by strains of S. pyogenes, S. pneumoniae, or S. aureus in mice with 50% protective dose (PD50) values of 0.6-2.4, 18-24, and 0.3-29 mg/kg, respectively. Formulations containing cefadroxil have been used in the treatment of a variety of bacterial infections.

1.Buck, R.E., and Price, K.E.Cefadroxil, a new broad-spectrum cephalosporinAntimicrob. Agents Chemother.11(2)324-330(1977)

Bewertungen

Review for Cefadroxil-d4 (trifluoroacetate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 8 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Cefadroxil-d4 (trifluoroacetate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.